- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06524908
Study on the Effectiveness of a School-Based Fat Loss Program for Adolescents
July 9, 2025 updated by: Aiyoudong Children and Youth Sports Health Research Institute
Study of the Effectiveness of an Exercise Intervention Oriented Toward Fat Loss in Adolescents
The students were divided into an intervention group and a control group.
The intervention group attended fat loss exercise classes three times a week and the parents cooperated with us in dietary monitoring and control.
Before and after the intervention, questionnaires were completed, physical fitness and body composition were measured, and physical activity measurement bracelets were worn for 4 days.
In this study, it is possible to know the mental health state, physical activity habits, body composition and physical fitness of adolescents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Weifang, Shandong, China, 261000
- Aiyoudong Children and Youth Sports Health Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Passed PAR-Q questionnaire screening
- No professional sports experience
- Able to understand the test
- Voluntarily participate in the entire testing process
Exclusion Criteria:
- Serious organic pathology of the heart, brain, lungs, kidneys, and locomotor system
- Taking medication for a chronic condition
- Have history of psychiatric disorders
- Inability to complete follow-up visits or poor adherence.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise and dietary calorie restriction intervention group
Received a twelve-week comprehensive intervention.
The number of participants is 50.
|
The intervention group received an exercise intervention three times a week (resistance exercise from 4:30-5:00 p.m. and aerobic exercise from 5:00-5:30 p.m.), and a caloric restriction intervention (guided semi-libre diet with caloric intake restricted to 75% of overall consumption, with parents keeping track of calories and food groups and receiving regular check-ups)
|
|
No Intervention: control group
Normal school life without any intervention.
The number of participants is 50.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body fat percentage (%)
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Measured by Inbody, a body composition tester using bioelectrical impedance, in %.
|
From enrollment to the end of intervention at 12 weeks
|
|
Physical fitness
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Measured using China National Standards for Students' Physical Health (2014 revision), with a minimum value of 0 and a maximum value of 100, higher scores respond to better fitness.
|
From enrollment to the end of intervention at 12 weeks
|
|
Physical activity
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Physical activity (PA) was measured using Actigraph GT3X+ accelerometers, with data expressed as minutes per day (min/day).
|
From enrollment to the end of intervention at 12 weeks
|
|
Fat-free mass
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Measured by Inbody, a body composition tester using bioelectrical impedance, in kg.
|
From enrollment to the end of intervention at 12 weeks
|
|
Fat mass
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Measured by Inbody, a body composition tester using bioelectrical impedance, in kg.
|
From enrollment to the end of intervention at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Salivary testosterone
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Salivary testosterone levels were measured using radioimmunoassay (RIA) and expressed in picograms per liter (pg/L).
|
From enrollment to the end of intervention at 12 weeks
|
|
Resilience
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Connor-Davidson Resilience Scale-10 (CD-RISC-10).
The scale consists of 10 items, each of which has a score range of 0-4, and the total score range of the scale is 0-40, with higher scores representing greater resilience.
|
From enrollment to the end of intervention at 12 weeks
|
|
Self-esteem
Time Frame: From enrollment to the end of intervention at 12 weeks
|
The Rosenberg Self-Esteem Scale was used, with a total of 10 items.
Scores on the scale range from 10 to 40, with higher scores indicating higher levels of self-esteem and better outcomes.
|
From enrollment to the end of intervention at 12 weeks
|
|
Aggression
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Assessed using the Buss-Perry Aggression Questionnaire with a total score range of 29-145.
The higher the score, the more aggressive the individual is in that area and the worse the outcome.
|
From enrollment to the end of intervention at 12 weeks
|
|
Eating Self-efficacy
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Eating Self-Efficacy Scale . The minimum score is 10 and the maximum score is 100. Higher scores indicate greater self-efficacy in eating and better outcomes. |
From enrollment to the end of intervention at 12 weeks
|
|
Exercise Self-Efficacy
Time Frame: From enrollment to the end of intervention at 12 weeks
|
Exercise Self-Efficacy Scale .
The minimum score is 18 and the maximum score is 180.
The higher the score, the stronger the self-efficacy in exercise and the better the result.
|
From enrollment to the end of intervention at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2022
Primary Completion (Actual)
December 10, 2022
Study Completion (Actual)
February 1, 2023
Study Registration Dates
First Submitted
June 27, 2024
First Submitted That Met QC Criteria
July 26, 2024
First Posted (Actual)
July 29, 2024
Study Record Updates
Last Update Posted (Actual)
July 10, 2025
Last Update Submitted That Met QC Criteria
July 9, 2025
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Basic-2334
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention
-
University of Puerto Rico Comprehensive Cancer...CompletedBreast Cancer Prevention | Colorectal Cancer Prevention | Cervical Cancer PreventionPuerto Rico
-
Brown UniversityNot yet recruitingFall | Fall Prevention | Fall Injury Prevention
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Institute of Nursing Research (NINR); Pennsylvania...CompletedPrevention Harmful Effects | Accidents, Traffic | Accident PreventionUnited States
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
University of California, San DiegoNational Center for Advancing Translational Sciences (NCATS); Sanford Burnham...Active, not recruitingFall Prevention | Fall Prevention in Healthy AgingUnited States
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
University of WashingtonNational Institute of Nursing Research (NINR)RecruitingFruit and Vegetable Consumption | Hispanic Americans | Cancer Prevention | Chronic Disease PreventionUnited States
-
University of St.GallenRecruiting
Clinical Trials on Exercise and dietary calorie restriction
-
St. Louis UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Shanghai Zhongshan HospitalCompletedType 2 Diabetes | Fatty Liver Disease | Impaired Glucose RegulationChina
-
University of South CarolinaCompleted
-
Lithuanian Sports UniversityCompletedObesity | Metabolic SyndromeLithuania
-
University of CologneFresenius KabiCompletedAcute Renal FailureGermany
-
University of AarhusUniversity of Southern Denmark; University GhentCompletedOverweight and ObesityDenmark
-
University of PernambucoUniversidade Federal de PernambucoEnrolling by invitationSarcopenia | Cardiac Disease | Metabolic Disease | Abdominal Obesity | Cardiometabolic SyndromeBrazil
-
SINEM BAYRAMCompletedObesity and Metabolic SyndromeTurkey
-
Usman Bin HameedWorld Health OrganizationCompletedDiabetes Mellitus, Type 2 | PreDiabetesPakistan